WO2002006479A3 - Apoptose-induzierende dna-sequenzen - Google Patents

Apoptose-induzierende dna-sequenzen Download PDF

Info

Publication number
WO2002006479A3
WO2002006479A3 PCT/EP2001/008170 EP0108170W WO0206479A3 WO 2002006479 A3 WO2002006479 A3 WO 2002006479A3 EP 0108170 W EP0108170 W EP 0108170W WO 0206479 A3 WO0206479 A3 WO 0206479A3
Authority
WO
WIPO (PCT)
Prior art keywords
apoptosis
dna sequences
inducing dna
relates
sequences
Prior art date
Application number
PCT/EP2001/008170
Other languages
English (en)
French (fr)
Other versions
WO2002006479A2 (de
Inventor
Stefan Grimm
Manuel Bauer
Nicole Schoenfeld
Erik Braziulis
Ursula Cramer
Andreas Gewies
Frank Voss
Thomas Mund
Timur Albayrak
Hendrik Gille
Matthias Klein
Original Assignee
Max Planck Gesellschaft
Stefan Grimm
Manuel Bauer
Nicole Schoenfeld
Erik Braziulis
Ursula Cramer
Andreas Gewies
Frank Voss
Thomas Mund
Timur Albayrak
Hendrik Gille
Matthias Klein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10126344A external-priority patent/DE10126344A1/de
Application filed by Max Planck Gesellschaft, Stefan Grimm, Manuel Bauer, Nicole Schoenfeld, Erik Braziulis, Ursula Cramer, Andreas Gewies, Frank Voss, Thomas Mund, Timur Albayrak, Hendrik Gille, Matthias Klein filed Critical Max Planck Gesellschaft
Priority to US10/332,859 priority Critical patent/US20040088746A1/en
Priority to EP01954041A priority patent/EP1349929A2/de
Priority to AU2001276406A priority patent/AU2001276406A1/en
Publication of WO2002006479A2 publication Critical patent/WO2002006479A2/de
Publication of WO2002006479A3 publication Critical patent/WO2002006479A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung betrifft neue Apoptose-assoziierte und insbesondere Apoptose-induzierende Nukleinsäuresequenzen, davon codierte Polypeptide und deren Verwendung zur Bereitstellung diagnostischer und therapeutischer Mittel. Zusätzlich betrifft die Erfindung Zellsysteme sowie transgene Tiere und deren Verwendung zur genetischen und/oder pharmakologischen Untersuchung von Apoptose-assoziierten Krankheiten.
PCT/EP2001/008170 2000-07-14 2001-07-13 Apoptose-induzierende dna-sequenzen WO2002006479A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/332,859 US20040088746A1 (en) 2000-07-14 2001-07-13 Apoptosis-inducing dna sequences
EP01954041A EP1349929A2 (de) 2000-07-14 2001-07-13 Apoptose-induzierende dna-sequenzen
AU2001276406A AU2001276406A1 (en) 2000-07-14 2001-07-13 Apoptosis-inducing dna sequences

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10034303.1 2000-07-14
DE10034303 2000-07-14
DE10126344.9 2001-05-30
DE10126344A DE10126344A1 (de) 2000-07-14 2001-05-30 Apoptose-induzierende DNA-Sequenzen

Publications (2)

Publication Number Publication Date
WO2002006479A2 WO2002006479A2 (de) 2002-01-24
WO2002006479A3 true WO2002006479A3 (de) 2003-07-17

Family

ID=26006388

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/008170 WO2002006479A2 (de) 2000-07-14 2001-07-13 Apoptose-induzierende dna-sequenzen

Country Status (3)

Country Link
EP (1) EP1349929A2 (de)
AU (1) AU2001276406A1 (de)
WO (1) WO2002006479A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486428B2 (en) 2006-03-27 2013-07-16 Board Of Regents, The University Of Texas System Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles
CA3085079A1 (en) 2013-03-13 2014-10-02 President And Fellows Of Harvard College Stapled and stitched polypeptides and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015084A1 (en) * 1993-11-30 1995-06-08 Lxr Biotechnology Inc. Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015084A1 (en) * 1993-11-30 1995-06-08 Lxr Biotechnology Inc. Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BAUER MANUEL K A ET AL: "Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis.", JOURNAL OF CELL BIOLOGY, vol. 147, no. 7, 27 December 1999 (1999-12-27), pages 1493 - 1501, XP002210088, ISSN: 0021-9525 *
DATABASE EMBL [online] 12 December 1996 (1996-12-12), MARRA M. ET AL.: "mq28f04.r1 Barstead MPLRB1 Mus musculus cDNA clone IMAGE:580063 5', mRNA sequence", XP002210091, retrieved from EBI Database accession no. AA137662 *
DATABASE EMBL [online] 29 March 1997 (1997-03-29), MARRA M. ET AL.: "vc15d05.r1 Barstead MPLRB1 Mus musculus cDNA clone IMAGE:766569 5', mRNA sequence", XP002210089, retrieved from EBI Database accession no. AA273529 *
DATABASE EMBL [online] MARRA M. ET AL.: "uc81e12.y1 Sugano mouse kidney mkia Mus musculus cDNA clone IMAGE:1432078 5', mRNA sequence.", XP002210090, retrieved from EBI Database accession no. AA986577 *
GRIMM STEFAN ET AL: "An apoptosis-inducing isoform of neu differentiation factor (NDS) identified using a novel screen for dominant, apoptosis-inducing genes.", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 185, no. 6, 1997, pages 1137 - 1142, XP000982878, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
AU2001276406A1 (en) 2002-01-30
WO2002006479A2 (de) 2002-01-24
EP1349929A2 (de) 2003-10-08

Similar Documents

Publication Publication Date Title
WO1999038972A8 (en) Human genes and gene expression products ii
WO2002014500A3 (en) Human genes and gene expression products
WO2001066753A3 (en) Human genes and gene expression products
WO1999033982A3 (en) Human genes and gene expression products i
NO20042570L (no) Antimikrobielle polypeptider fra Pseudoplectania nigrella
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2001034809A3 (en) Staphylococcus epidermidis nucleic acids and proteins
WO2001064877A3 (en) Human schizophrenia gene
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2002006479A3 (de) Apoptose-induzierende dna-sequenzen
WO2002018576A3 (en) Compositions and methods relating to lung specific genes
WO2001000643A3 (en) Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
WO2001064876A3 (en) Human schizophrenia gene
DE60125156D1 (de) Nicht-menschliche sperm-dns zubereitungen zur genetischen veränderung nicht-menschlicher tiere
AU6928700A (en) Identifying organisms by detecting intronic nucleic acid or encoded proteins
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO2001072781A3 (en) Human genes and expression products
WO2004108757A3 (en) Antimicrobial polypeptides
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO1997040134A3 (en) Human dnase ii
WO2003018629A8 (en) Cage antigen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001954041

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10332859

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001954041

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001954041

Country of ref document: EP